Hartline Investment Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-32,097
Closed -$503K 116
2019
Q1
$503K Buy
32,097
+125
+0.4% +$1.96K 0.13% 86
2018
Q4
$493K Sell
31,972
-150
-0.5% -$2.31K 0.15% 83
2018
Q3
$692K Sell
32,122
-125
-0.4% -$2.69K 0.16% 81
2018
Q2
$784K Sell
32,247
-1,785
-5% -$43.4K 0.21% 69
2018
Q1
$582K Sell
34,032
-470
-1% -$8.04K 0.16% 80
2017
Q4
$654K Sell
34,502
-3,001
-8% -$56.9K 0.18% 80
2017
Q3
$660K Hold
37,503
0.2% 79
2017
Q2
$1.25M Buy
37,503
+200
+0.5% +$6.65K 0.4% 58
2017
Q1
$1.2M Sell
37,303
-345
-0.9% -$11.1K 0.39% 61
2016
Q4
$1.37M Sell
37,648
-1,125
-3% -$40.8K 0.48% 54
2016
Q3
$1.78M Sell
38,773
-39
-0.1% -$1.79K 0.64% 41
2016
Q2
$1.95M Sell
38,812
-20
-0.1% -$1.01K 0.7% 36
2016
Q1
$2.08M Hold
38,832
0.76% 34
2015
Q4
$2.55M Buy
38,832
+6,169
+19% +$405K 0.95% 29
2015
Q3
$1.84M Sell
32,663
-7,694
-19% -$434K 0.67% 35
2015
Q2
$2.39M Sell
40,357
-266
-0.7% -$15.7K 0.79% 41
2015
Q1
$2.53M Sell
40,623
-89
-0.2% -$5.55K 0.83% 38
2014
Q4
$2.34M Hold
40,712
0.78% 39
2014
Q3
$2.19M Sell
40,712
-55
-0.1% -$2.96K 0.79% 41
2014
Q2
$2.14M Sell
40,767
-30
-0.1% -$1.57K 0.77% 43
2014
Q1
$2.16M Buy
40,797
+120
+0.3% +$6.34K 0.74% 48
2013
Q4
$1.63M Hold
40,677
0.57% 54
2013
Q3
$1.54M Hold
40,677
0.6% 53
2013
Q2
$1.6M Buy
+40,677
New +$1.6M 0.64% 51